Publication | Open Access
The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer
38
Citations
20
References
2016
Year
In patients with ER+ IBC receiving NCT, RS did not predict response to NCT using %TR. The benefit of the assay prior to NCT requires further study.
| Year | Citations | |
|---|---|---|
Page 1
Page 1